166 related articles for article (PubMed ID: 15461573)
1. Applications of gene therapy for familial amyloidotic polyneuropathy.
Nakamura M; Ando Y
Expert Opin Biol Ther; 2004 Oct; 4(10):1621-7. PubMed ID: 15461573
[TBL] [Abstract][Full Text] [Related]
2. [Gene therapy in familial amyloidotic polyneuropathy by single-stranded oligonucleotides (SSOs)].
Nakamura M; Ando Y
Rinsho Byori; 2004 Oct; 52(10):804-12. PubMed ID: 15624495
[TBL] [Abstract][Full Text] [Related]
3. Suppression of transthyretin expression by ribozymes: a possible therapy for familial amyloidotic polyneuropathy.
Tanaka K; Yamada T; Ohyagi Y; Asahara H; Horiuchi I; Kira J
J Neurol Sci; 2001 Jan; 183(1):79-84. PubMed ID: 11166799
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
Ando Y
Amyloid; 2003 Aug; 10 Suppl 1():55-66. PubMed ID: 14640043
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
Ando Y
Med Mol Morphol; 2005 Sep; 38(3):142-54. PubMed ID: 16170462
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy approach to FAP: in vivo influence of T119M in TTR deposition in a transgenic V30M mouse model.
Batista AR; Gianni D; Ventosa M; Coelho AV; Almeida MR; Sena-Esteves M; Saraiva MJ
Gene Ther; 2014 Dec; 21(12):1041-50. PubMed ID: 25273354
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenesis and therapy for transthyretin related amyloidosis].
Ando Y; Jono H
Rinsho Byori; 2008 Feb; 56(2):114-20. PubMed ID: 18402051
[TBL] [Abstract][Full Text] [Related]
8. Familial amyloidotic polyneuropathy and transthyretin.
Nagasaka T
Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
[TBL] [Abstract][Full Text] [Related]
9. [Effect of liver trasplantation on familial amyloidotic polyneuropathy (FAP) and its limt].
Ando Y
Rinsho Shinkeigaku; 2011 Nov; 51(11):1138-41. PubMed ID: 22277510
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in the understanding and treatment of transthyretin amyloidosis.
Sekijima Y
J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Oligonucleotide-Based Therapy for Transthyretin Amyloidosis: Clinical Impact and Future Prospects.
Hayashi Y; Jono H
Biol Pharm Bull; 2018; 41(12):1737-1744. PubMed ID: 30504675
[TBL] [Abstract][Full Text] [Related]
12. Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.
Araki S; Ando Y
Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(7):694-706. PubMed ID: 20689228
[TBL] [Abstract][Full Text] [Related]
13. Novel methods for detecting amyloidogenic proteins in transthyretin related amyloidosis.
Ando Y; Ueda M
Front Biosci; 2008 May; 13():5548-58. PubMed ID: 18508604
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic strategy for familial amyloid polyneuropathy (FAP)].
Ikeda S
Rinsho Shinkeigaku; 2009 Nov; 49(11):953-5. PubMed ID: 20030258
[TBL] [Abstract][Full Text] [Related]
15. [Application to transthyretin analysis].
Ueda M; Ando Y
Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
[TBL] [Abstract][Full Text] [Related]
16. Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.
Schmidt HH; Barroso F; González-Duarte A; Conceição I; Obici L; Keohane D; Amass L
Muscle Nerve; 2016 Sep; 54(3):353-60. PubMed ID: 27273296
[TBL] [Abstract][Full Text] [Related]
17. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
Ikeda S; Nakazato M; Ando Y; Sobue G
Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis.
Niemietz C; Chandhok G; Schmidt H
Molecules; 2015 Sep; 20(10):17944-75. PubMed ID: 26437390
[TBL] [Abstract][Full Text] [Related]
19. Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy.
Ackermann EJ; Guo S; Booten S; Alvarado L; Benson M; Hughes S; Monia BP
Amyloid; 2012 Jun; 19 Suppl 1():43-4. PubMed ID: 22494066
[TBL] [Abstract][Full Text] [Related]
20. A non-invasive method based on saliva to characterize transthyretin in familial amyloidotic polyneuropathy patients using FT-ICR high-resolution MS.
da Costa G; Guerreiro A; Correia CF; Gomes RJ; Freire A; Monteiro E; Barroso E; Coelho AV; Outeiro TF; Freire AP; Cordeiro C
Proteomics Clin Appl; 2010 Jul; 4(6-7):674-8. PubMed ID: 21179887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
